CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Early monotherapy with pegylated interferon alfa–2b for acute hepatitis C infection: Final Results of the German HEP-NET Acute HCV II Study
DOI 10.1055/s-2005-920086
Bibliografische Angaben
Nachweis in CareLit
Autor:innenJ Wiegand, P Buggisch, W Böcher, S Zeuzem, CM Gelbmann, T Berg, W Kauffmann, B Kallinowski, M Cornberg, E Jäckel, H Wedemeyer, MP Manns
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe04/2006
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: Early treatment of acute hepatitis C with interferon alfa–2b for 24 weeks effectively prevents chronic infection. Since the standard therapy of chronic hepatitis C has changed from conventional to pegylated interferons the aim of this multicenter nation-wide study was to analyze the efficacy of an early treatment with pegylated interferon alfa–2b in patients with acute hepatitis C. Methods: Between Feb…
Zitieren
Zitierempfehlung
J Wiegand, P Buggisch, W Böcher, S Zeuzem, CM Gelbmann, T Berg, W Kauffmann, B Kallinowski, M Cornberg, E Jäckel, H Wedemeyer, MP Manns (2006) Early monotherapy with pegylated interferon alfa–2b for acute hepatitis C infection: Final Results of the German HEP-NET Acute HCV II Study. Zeitschrift für Gastroenterologie (04). https://doi.org/10.1055/s-2005-920086
Mit CareLit weiterarbeiten